| GILDGILEAD SCIENCES, INC. | 1,264,546 | $176.2M |
| ARGXARGENX SE | 237,468 | $173.4M |
| SRRKScholar Rock Holding Corp | 3,340,492 | $164.2M |
| ARQTArcutis Biotherapeutics, Inc. | 4,980,770 | $117.3M |
| PTGXProtagonist Therapeutics, Inc | 1,072,011 | $113.0M |
| INSMINSMED Inc | 604,694 | $98.9M |
| PCVXVaxcyte, Inc. | 1,698,011 | $98.7M |
| REGNREGENERON PHARMACEUTICALS, INC. | 115,199 | $89.0M |
| NAMSNEWAMSTERDAM PHARMA CO N.V. | 2,750,403 | $88.0M |
| ROIVRoivant Sciences Ltd. | 2,982,799 | $82.6M |
| PVLAPALVELLA THERAPEUTICS, INC. | 640,611 | $79.9M |
| IMVTImmunovant, Inc. | 3,196,705 | $79.4M |
| SIONSionna Therapeutics, Inc. | 1,451,220 | $58.2M |
| APGEApogee Therapeutics, Inc. | 585,016 | $49.2M |
| ONCBeOne Medicines Ltd. | 154,465 | $45.9M |
| TEVATeva Pharmaceutical Industries Limited | 1,439,151 | $43.3M |
| DNTHDianthus Therapeutics, Inc. /DE/ | 485,136 | $40.7M |
| IRONDisc Medicine, Inc. | 610,382 | $39.0M |
| RVMDREVOLUTION MEDICINES, INC. | 307,377 | $29.9M |
| OLMAOlema Pharmaceuticals, Inc. | 1,822,123 | $27.2M |
| TERNTerns Pharmaceuticals, Inc. | 501,419 | $26.4M |
| ABVXAbivax SA | 210,534 | $23.4M |
| QUREuniQure N.V. | 1,233,789 | $20.2M |
| LBRXLB PHARMACEUTICALS INC | 538,216 | $13.3M |
| ELVNEnliven Therapeutics, Inc. | 309,180 | $12.1M |
| NGNENeurogene Inc. | 527,685 | $10.6M |
| RZLTRezolute, Inc. | 3,438,881 | $10.5M |
| ADPTAdaptive Biotechnologies Corp | 753,073 | $10.5M |
| MANEVeradermics Incorporated | 141,781 | $9.0M |
| ORKAOruka Therapeutics, Inc. | 176,680 | $8.7M |
| AVTXAvalo Therapeutics, Inc. | 470,775 | $7.0M |
| ZBIOZenas BioPharma, Inc. | 250,000 | $4.9M |
| CBIOCRESCENT BIOPHARMA, INC. | 152,974 | $2.8M |
| INVAInnoviva, Inc. | 69,767 | $1.6M |
| DFTXDefinium Therapeutics Inc. | 39,957 | $755K |
| OCULOCULAR THERAPEUTIX, INC | 72,511 | $614K |
| VRDNViridian Therapeutics, Inc.\DE | 28,059 | $549K |